Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

By sjmartinez • July 5, 2022

Yamamura T, Weinshenker B, Yeaman MR, De Seze J, Patti F, Lobo P, von Büdingen HC, Kou X, Weber K, Greenberg B. Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar. Mult Scler Relat Disord. 2022 Jul 5;66:104025. doi: 10.1016/j.msard.2022.104025. Epub ahead of print. PMID: 36007339.

All clinical trials, All demyelinating disease (CNS), Autoimmune diseases, Devic's syndrome, Neuromyelitis optica spectrum disorder, Patient safety,

Tags: Digestive Diseases, Publications

Short-term outcomes of laparoscopic hiatal hernia repair with consecutive transoral incisionless fundoplication (cTIF): a prospective multicenter cohort study

Kolb JM, Canto MI, Parker B, Murray M, Brewer Gutierrez OI, Sharaiha RZ, Samarasena J, Thosani NC, Abu-Dayyeh BK, Janu P, Chang KJ, Nguyen NT.[...]

Decreased degree of adipocyte differentiation in visceral adipose tissue contributes to metabolic dysfunction-associated steatotic liver disease

Gelev KZ, Lee SHT, Alvarez M, Mancina RM, Tavaglione F, Jamialahmadi O, Vespasiani-Gentilucci U, Kar A, Wang Z, Kaminska D, Kaikkonen MU, Männistö V, Heinonen[...]

Summarization of Narrative Clinical Data of Inflammatory Bowel Disease With Foundational Large Language Models

Hong S, Greb AC, Shah-Riar P, Zheng HM, Limketkai BN. Summarization of Narrative Clinical Data of Inflammatory Bowel Disease With Foundational Large Language Models. Gastro[...]